EXPERIENCE*
2019 - Present, Istanbul/Istanbul/Turkey
MEMORIAL ATAŞEHİR HOSPITAL
General Surgeon
2012 - 2019, Diyarbakır/Diyarbakır/Turkey
DİCLE UNIVERSITY FACULTY OF MEDICINE
General Surgeon
2011 - 2012, Van/Van/Turkey
VAN REGIONAL TRAINING AND RESEARCH HOSPITAL
General Surgeon
2009 - 2011, Van/Van/Turkey
HAKKARİ STATE HOSPITAL
General Surgeon
2004 - 2009, Van/Van/Turkey
YÜZÜNCÜYIL UNIVERSITY FACULTY OF MEDICINE
General Surgeon
2002 - 2004, Van/Van/Turkey
HACIBEKİR HEALTH CENTER
General Practitioner
*EDUCATION*
2018 - 2019, Diyarbakır/Turkey
Associate Professor
2015, Ohio/USA
OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER
Neck Dissection Training
2012 - 2018, Diyarbakır/Turkey
Assistant Professor
1996 - 2002, Adana/Turkey
ÇUKUROVA UNIVERSITY
FACULTY OF MEDICINE - Medical Doctor Education
Read moreAfter receiving his Medical Degree, Board Certification in Allergy and Clinical Immunology, and PhD in Basic and Applied Immunology, Dr. Della Torre worked for 3 years in the United States at the “Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT), and Harvard Medical School” in Boston. Thanks to a Cariplo Foundation research grant, Dr. Della Torre returned to Italy in 2018 and established his lab within the Division of Genetic and Cell Biology of San Raffale Hospital (Milan, Italy).
Dr. Della Torre is now Assistant Professor of Rheumatology at Vita-Salute San Raffaele University and Senior Consultant at the Unit of Immunology, Rheumatology, Allergy, and Rare Disease (UnIRAR) of San Raffaele Hospital.
Dr. Della Torre authored more than 100 scientific publications on international peer-reviewed journals and achieved prestigious awards such as the Collegio Ghislieri and the Cariplo Foundation awards for young researchers, the TRIDEO award, the MyFirst AIRC research grant, and the Career Research Grant Award from the FOREUM Foundation.
With his seminal works Dr. Della Torre contributed to the characterization of a novel autoimmune disease known as “IgG4-related disease” and is currently considered “World Expert of IgG4-related disease” by the prestigious Expertscape platform.
Dr. Della Torre is the Disease Coordinator of the IgG4-related disease European working group of the European Reference Network (ERN) on Rare Connective Tissue and Musculoskeletal Diseases (ReCONNET).
Up to September 2022, his scientific publications received more than 6000 citations with an H-index of 35.
Dr. Della Torre presented his studies in different national and international immune-rheumatologic congresses, organized a number of scientific meetings, and co-authored 10 medical books. He presently serves as reviewer for more than 50 peer-reviewed journals and as associated editor for three international scientific journals. Dr. Della Torre is a Head of the:
Dr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following:
Head of Nephrology Department, specializes in the diagnosis and treatment of renal diseases
Read more